Demonstration of distinct pathways of mast cell‐dependent inhibition of Treg generation using murine bone marrow‐derived mast cells
- 9 March 2020
- Vol. 75 (8), 2088-2091
- https://doi.org/10.1111/all.14267
Abstract
No abstract availableFunding Information
- National Institute of Allergy and Infectious Diseases (R01 AI093577, R21 AI124062)
This publication has 9 references indexed in Scilit:
- Phase 2a randomized, placebo-controlled study of anti–IL-33 in peanut allergyJCI Insight, 2019
- Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 studyThe Lancet, 2019
- Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergyNature Medicine, 2019
- Immune Characterization of Bone Marrow-Derived Models of Mucosal and Connective Tissue Mast CellsAllergy, Asthma & Immunology Research, 2018
- A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergyJournal of Allergy and Clinical Immunology, 2015
- Induction of Interleukin-9-Producing Mucosal Mast Cells Promotes Susceptibility to IgE-Mediated Experimental Food AllergyImmunity, 2015
- Randomized Trial of Peanut Consumption in Infants at Risk for Peanut AllergyNew England Journal of Medicine, 2015
- Immunoglobulin E Signal Inhibition during Allergen Ingestion Leads to Reversal of Established Food Allergy and Induction of Regulatory T CellsImmunity, 2014
- Intestinal Mast Cell Levels Control Severity of Oral Antigen-Induced Anaphylaxis in MiceThe American Journal of Pathology, 2012